San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Aethlon Subsidiary to Collaborate With Thomas Jefferson University in Cancer Research

San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.

By Brittany Meiling April 3, 2015 1:04 p.m.   Share

Alastin Skincare Inc. Names New President/CEO

Alastin Skincare Inc., a specialty skin care company in Carlsbad, announced the appointment of Diane Goostree as its new president and CEO.

Biocept's Liquid Biopsy OK'd For Use by 2 PPO Networks

Molecular diagnostic firm Biocept announced Monday that it has signed two new agreements with preferred provider organization networks — Fortified Provider Network and Three Rivers Provider Network.

Tease photo

Perry Nisen Named to California Life Sciences Association Board

The California Life Sciences Association announced Monday that Perry Nisen, CEO of Sanford Burnham Prebys Medical Discovery Institute, will join its board of directors.

Board Appointment Gives AnaptysBio Inc. More Commercialization Experience

AnaptysBio Inc., a biotech developing antibody products for inflammation and cancer, announced the appointment of James A. Schoeneck to its board of directors.

Otonomy Inc. Enrolling Patients for Phase 3 Clinical Trial of Ménière’s Disease Treatment

San Diego-based Otonomy Inc., a company that makes treatments for the middle and inner ear, is enrolling the first patients in a Phase 3 clinical trial of OTO-104 for Ménière’s disease, an inner ear disorder characterized by severe dizziness, vertigo, and gradual hearing loss.

Tease photo

West Health Institute to Donate Autism Research Technology

San Diego’s Gary and Mary West Health Institute will donate its technical and clinical assets of its autism research program to Northeastern University’s Bouvé College of Health Sciences in order to develop more effective interventions for the disorder.

Sharp Selects Design-Build Team for Hospital Expansion

Sharp Chula Vista Medical Center is building a $239 million hospital to keep up with demand in South County.

AmpliPhi Biosciences to Conduct Clinical Trial With University of Adelaide

San Diego-based AmpliPhi Biosciences announced that it has signed a clinical trial agreement with the University of Adelaide to conduct a Phase 1 trial of bacteriophage therapy.

Tease photo

Halozyme Therapeutics to Open Satellite Office in San Francisco

Halozyme Therapeutics, a biotechnology company developing novel oncology and drug-delivery therapies, announced it will expand and open a satellite office in San Francisco.

AMN Healthcare Acquires Kansas-Based Staffing Firm for $160 Milllion

AMN Healthcare Services Inc. announced that it will acquire global health care staffing firm Lenexa, Kan.-based B.E. Smith for $160 million in cash.

Sabra Matovsky Tapped to Lead New Primary Care Network

The Council of Community Clinics announced the formation of a new primary care network called Integrated Health Partners, and the appointment of senior health care executive Sabra Matovsky to lead the new venture.

Tease photo

Nobel Laureate Elizabeth Blackburn Named Salk Institute President

The Salk Institute for Biological Studies has named Nobel Prize-winning scientist Elizabeth Blackburn as president.

Viking Therapeutics Files IND Application

Viking Therapeutics, a biopharmaceutical firm, announced Tuesday that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration for a product candidate meant to treat high cholesterol and fatty liver disease.

Illumina Inc. to Get Spot on Standard & Poor's 500 Stock Index

Illumina Inc. will get a place on the Standard & Poor’s 500 stock index after the close of trading on Wednesday, Nov. 18.

Ambrx Names Chief Medical Officer

La Jolla-based Ambrx announced the appointment of Dr. Yong-Jiang Hei as chief medical officer, reporting directly to CEO Tiecheng "Alex" Qiao.